Brca1-deficient murine mammary epithelial cells have increased sensitivity to CDDP and MMS

被引:46
作者
Sgagias, MK
Wagner, KU
Hamik, B
Stoeger, S
Spieker, R
Huber, LJ
Chodosh, LA
Cowan, KH
机构
[1] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[2] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
关键词
Bcra1-deficiency; DNA-damage and repair; breast cancer; CDDP; MMS;
D O I
10.4161/cc.3.11.1211
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this report we describe the isolation of an isogenic pair of Brca1(++) and Brca1(-/-) murine mammary epithelial cells (MMECs). These cells were isolated from Brca1 conditional knock-out mice which contained loxP sites flanking exon 11 of the Brca1 gene (Brca1(f1/f1)) and then immortalized by infection with HPV-16E6 retrovirus to degrade p53 protein. Brca1-/- MMECs were generated by deletion of exon 11 following transduction of Brca1(f1/f1) MMECs with a retroviral vector expressing Cre recombinase. Brca1-deficiency rendered MMECs sensitive to cis-platinum (II) diamine dichloride ( CDDP) and methylmethane sulfonate (MMS). The Brca1(+/+) and Brca1(-/-) MMECs is the only known pair of isogenic mammary epithelial cell lines. The understanding of the mechanisms of the CDDP sensitivity of the BRCA1-deficient mammary epithelial cells would be very important in understanding how BRCA1-deficiency plays a role in tissue specific breast cancer chemotherapy. These studies support the role of BRCA1 in the CDDP-induced and MMS-induced DNA damage and repair by p53-independent pathways.
引用
收藏
页码:1451 / 1456
页数:6
相关论文
共 48 条
[31]  
Quinn JE, 2003, CANCER RES, V63, P6221
[32]   The genetics of breast cancer susceptibility [J].
Rahman, N ;
Stratton, MR .
ANNUAL REVIEW OF GENETICS, 1998, 32 :95-121
[33]   Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer [J].
Rogan, EG ;
Badawi, AF ;
Devanesan, PD ;
Meza, JL ;
Edney, JA ;
West, WW ;
Higginbotham, SM ;
Cavalieri, EL .
CARCINOGENESIS, 2003, 24 (04) :697-702
[34]   Association of BRCA1 with Rad51 in mitotic and meiotic cells [J].
Scully, R ;
Chen, JJ ;
Plug, A ;
Xiao, YH ;
Weaver, D ;
Feunteun, J ;
Ashley, T ;
Livingston, DM .
CELL, 1997, 88 (02) :265-275
[35]   Genetic analysis of BRCA1 function in a defined tumor cell line [J].
Scully, R ;
Ganesan, S ;
Vlasakova, K ;
Chen, JJ ;
Socolovsky, M ;
Livingston, DM .
MOLECULAR CELL, 1999, 4 (06) :1093-1099
[36]   Implication of p53 in base excision DNA repair:: in vivo evidence [J].
Seo, YR ;
Fishel, ML ;
Amundson, S ;
Kelley, MR ;
Smith, ML .
ONCOGENE, 2002, 21 (05) :731-737
[37]   MURINE BRCA1 - SEQUENCE AND SIGNIFICANCE FOR HUMAN MISSENSE MUTATIONS [J].
SHARAN, SK ;
WIMS, M ;
BRADLEY, A .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2275-2278
[38]   Ovarian cancer in BRCA-positive women: vigilance is mandatory despite screening programs [J].
Sloots, K ;
Ausems, MGEM ;
de Haan, HH .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 101 (02) :196-198
[39]   The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair [J].
Starita, LM ;
Parvin, JD .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (03) :345-350
[40]   BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines [J].
Thangaraju, M ;
Kaufmann, SH ;
Couch, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33487-33496